Myriad Genetics (NASDAQ: MYGN) director receives 59,701 restricted stock units

Rhea-AI Filing Summary

Reitan Colleen F reported acquisition or exercise transactions in this Form 4 filing.

MYRIAD GENETICS INC director Colleen F. Reitan received an equity grant of 59,701 shares of common stock in the form of restricted stock units under the company’s 2026 Employee, Director and Consultant Equity Incentive Plan. Following this award, she directly holds 152,030 shares of common stock.

Each restricted stock unit represents a right to receive one share of common stock and will vest upon the earlier of the first anniversary of the grant date or the date of the next annual meeting of stockholders after the grant. This is a compensation-related award rather than an open-market share purchase.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Reitan Colleen F

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	59,701	$0.00	--

Holdings After Transaction: Common Stock — 152,030 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSU grant size: 59,701 shares Price per share for grant: $0.00 per share Total shares after transaction: 152,030 shares +2 more

5 metrics

RSU grant size 59,701 shares Restricted stock units granted to director on reported date

Price per share for grant $0.00 per share Equity award granted at no cash cost to director

Total shares after transaction 152,030 shares Director’s direct holdings following RSU grant

Transaction code A Grant, award, or other acquisition of non-derivative common stock

Vesting condition Earlier of 1 year or next annual meeting RSUs vest on the first anniversary or next stockholder meeting date

Key Terms

restricted stock units, 2026 Employee, Director and Consultant Equity Incentive Plan, contingent right, vests, +1 more

5 terms

restricted stock units financial

"Consists of restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

2026 Employee, Director and Consultant Equity Incentive Plan financial

"granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan, as amended"

contingent right financial

"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock"

vests financial

"and vests upon the earlier of (a) the first anniversary of the date of grant"

annual meeting of stockholders financial

"or (b) the date of the next annual meeting of stockholders following such grant"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Reitan Colleen F

(Last) (First) (Middle)

322 NORTH 2200 WEST

(Street)

SALT LAKE CITY UTAH 84116

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MYRIAD GENETICS INC [ MYGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/04/2026		A		59,701(1)	A	$0	152,030	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Consists of restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant.

Remarks:

	By: Justin Hunter For: Colleen F. Reitan	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did MYGN director Colleen Reitan report in this Form 4 filing?

Director Colleen F. Reitan reported receiving 59,701 restricted stock units of MYRIAD GENETICS INC common stock as an equity award. These units are part of her compensation and increase her direct holdings to 152,030 shares after the grant.

Is Colleen Reitan’s MYGN Form 4 transaction a stock purchase or a grant?

The Form 4 shows an equity grant, not a market purchase. Colleen Reitan received 59,701 restricted stock units at no cash cost under Myriad Genetics’ 2026 equity incentive plan, reflecting compensation instead of an open-market buy or sell transaction.

How many MYGN shares does Colleen Reitan hold after this reported grant?

After receiving 59,701 restricted stock units, Colleen Reitan’s direct holdings total 152,030 shares of Myriad Genetics common stock. This figure reflects her position immediately following the equity award disclosed in the Form 4 insider trading report.

When do the restricted stock units granted to Colleen Reitan for MYGN vest?

The restricted stock units vest on the earlier of two dates: the first anniversary of the grant date or the date of the next annual meeting of stockholders. Once vested, each unit converts into one share of Myriad Genetics common stock.

Under which plan were Colleen Reitan’s MYGN restricted stock units granted?

The restricted stock units were granted under Myriad Genetics’ 2026 Employee, Director and Consultant Equity Incentive Plan, as amended. This plan governs equity awards such as RSUs for employees, directors, and consultants of the company.